Dr. Markus Steilemann to Take Over as Covestro CEO From June
German material science company, Covestro’s CEO Mr. Patrick Thomas will hand over charge to Dr. Markus Steilemann, currently Chief Commercial Officer (CCO), on June 1, 2018.
The company said its Supervisory Board has agreed on an amicable retirement of Mr. Thomas’ tenure as CEO effective May 31, 2018. Mr. Thomas contract as CEO would have originally ended on September 30, 2018. In May last year, Mr. Thomas had informed the Board that he would not be available for a further term beyond 2018. Subsequently, the Board appointed Dr. Steilemann as his successor as CEO of Covestro. Mr. Tho-mas has been CEO of Covestro and its predecessor Bayer MaterialScience since 2007.
2026-08-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
German chemical exports expected to fall
-
ECHEMI German Site (de.echemi.com) is now online!
-
German national treasure brand 4711 new remix cologne launched!
-
German industrial output slumps again in July, heightening recession fears
-
German Business Prosperity Index Continued to Drop
-
Wanhua Shuts 1.1 Million-Tonne Yantai MDI Unit for 45-Day Maintenance
-
“Changing the Captain at Sea”: Hempel’s CEO Departs to Run a Ferry Giant—This Isn’t a Resignation Notice, It’s an Industry Stress Map
-
Global Biologicals M&A Storm: How 2025 Redrew the Agricultural Innovation Map
-
Australia Launches Anti-Circumvention Trade Probe into China’s 2,4-D Supply Chain
-
He Spent 40 Years at Nestlé—Then Was “Cleared Out” Days After Becoming CEO: This Isn’t a Scandal, It’s Capital’s Coldest Face
Recommend Reading
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Lubrizol Announces Elimination of PFAS from Its Peptide Synthesis Process
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Remote Raw Material Boost, PC Prices Recover After Falling in the First Half of July in China
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
Cost-side Speculative Sentiment Rises, PP Strongly Rebounds in Early July
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate